CYP INHIBITION SCREEN FOR DRUG DISCOVERY USING CASSETTE ANALYSIS AND COLUMN SWITCHING

被引:0
|
作者
Libedinsky, Ronitte T. [1 ]
Zhang, Chenghong [1 ]
Wang, Susan [1 ]
Halladay, Jason [1 ]
Khojasteh-Bakht, S. Cyrus [1 ]
机构
[1] Genentech Inc, Dept DMPK, San Francisco, CA 94080 USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
440
引用
收藏
页码:316 / 317
页数:2
相关论文
共 50 条
  • [1] Metabolic stability screen for drug discovery using cassette analysis and column switching
    Halladay, Jason Steven
    Wong, Susan
    Merchant, Sharmin
    Khojasteh-Bakht, S. Cyrus
    Sinhababu, Achintya
    DRUG METABOLISM REVIEWS, 2006, 38 : 149 - 149
  • [2] EVALUATION OF CASSETTE DOSING TO SCREEN CNS COMPOUNDS IN DRUG DISCOVERY
    Deshmukh, Gauri
    Chen, Jacob
    Chou, Bilin
    Liederer, Bianca
    DRUG METABOLISM REVIEWS, 2014, 45 : 53 - 54
  • [3] Fast, efficient separations in drug discovery - LC-MS analysis using column switching and rapid gradients
    Needham, SR
    LC GC NORTH AMERICA, 2000, 18 (11) : 1156 - +
  • [4] DEVELOPMENT OF A DISCOVERY CYP INHIBITION SCREEN FOR EARLY IDENTIFICATION OF DDI LIABILITIES
    Sierra, Teresa
    Strock, Christopher
    Wyglinski, Joanne
    Bradley, Jenifer
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : S38 - S38
  • [5] Behind the screen: drug discovery using the big data of phenotypic analysis
    Froney, Merrill M.
    Jarstfer, Michael B.
    Pattenden, Samantha G.
    Solem, Amanda C.
    Aina, Olubunmi O.
    Eslinger, Melissa R.
    Thomas, Aeisha
    Alexander, Courtney M.
    FRONTIERS IN EDUCATION, 2024, 9
  • [6] Rapid CYP 450 inhibition profiling in discovery drug metabolism and pharmacokinetics
    Rigby, Christine E.
    Hallworth, Sebastian R.
    Davies, Emma J.
    Litten, Brett
    DRUG METABOLISM REVIEWS, 2006, 38 : 46 - 46
  • [7] A new generic column switching system for quantitation in cassette dosing using LC/MS/MS
    Ohkawa, T
    Ishida, Y
    Kanaoka, E
    Takahashi, K
    Okabe, H
    Matsumoto, T
    Nakamoto, S
    Tamada, J
    Koike, M
    Yoshikawa, T
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 31 (06) : 1089 - 1099
  • [8] Assessing and minimizing time-dependent inhibition of CYP3A in drug discovery
    Tang, Wei
    DRUG METABOLISM REVIEWS, 2009, 41 : 77 - 77
  • [9] Structure-based ligand design to overcome CYP inhibition in drug discovery projects
    Branden, Gisela
    Sjogren, Tove
    Schnecke, Volker
    Xue, Yafeng
    DRUG DISCOVERY TODAY, 2014, 19 (07) : 905 - 911
  • [10] The use of pharmacophore and protein models to predict CYP inhibition and substrates in drug discovery research
    Andersson, TB
    DRUG METABOLISM REVIEWS, 2003, 35 : 9 - 9